Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • AYUSH
    • Monitoring, regulating...

    Monitoring, regulating misleading ads for promoting Ayush medicine sale vital: Report

    Written by Ruby Khatun Khatun Published On 2018-04-30T10:00:53+05:30  |  Updated On 30 April 2018 10:00 AM IST
    Monitoring, regulating misleading ads for promoting Ayush medicine sale vital: Report

    New Delhi: It is the need of the hour to strictly monitor and regulate the misleading advertisements for promoting the sale of Ayush medicine, a report said here.


    A Parliamentary Standing Committee report on Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homeopathy(AYUSH) Ministry was of the view that collaborative efforts of the ministry along with the Department of Consumer Affairs, Information and Broadcasting ministry and state governments have certainly given results as misleading advertisements with respect to ASU&H drugs, which have been unregulated so far, have been controlled to an extent.


    Appreciating the efforts made by Ayush ministry, the panel said due to monitoring by Advertising Standards Council of India (ASCI) and the Grievances against Misleading advertisements (GAMA), 65 percent of the advertisements found misleading were withdrawn or rectified and the rest forwarded to state Ayush Drug Regulators.


    The Committee was of the view that a strong and strict regulatory framework was essential for quality control of ASU&H drugs. Since the states are responsible to for quality control and regulation of Ayush drugs, they need financial assistance so as to strengthen their regulatory framework.


    The panel noted that financial aid given to states was not much and therefore recommended significant enhancement of the same.


    The Committee, headed by Prof Ram Gopal Yadav, also expressed concern about the issue of failed samples of ASU drugs and the consequent action taken in this regard. The panel was of the strong view that merely issuing show cause notice, departmental action among others was not sufficient to control the menace of spurious Ayush drugs.


    Despite repeated recommendations of the Committee to have stringent measures to tackle the problem of failed samples, the ministry seemed not to have done anything in this regard. Taking serious note of the lackadaisical approach of the ministry in not taking concrete action against defaulters, the Committee emphasized that erring manufacturers need to be brought to book and dealt with strictly for misleading and duping innocent patients and playing with their lives.


    The Committee accordingly recommended to the ministry to lay down stringent regulations which can act as a deterrent for erring manufacturers.

    Advertising Standards Council of IndiaAyurvedaAyush medicinesDepartment of Consumer AffairsHomeopathyInformation and Broadcasting Ministrymisleading adsmisleading advertisementsMonitoringParliamentary Standing Committeepromotingregulating
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok